Prague, Czech Republic

ELCC 2024

The European Lung Cancer Congress (ELCC 2024) is a collaborative effort of important multidisciplinary societies representing thoracic oncology specialists, working together to advance science, disseminate education and improve the practice of lung cancer specialists worldwide. 

Medical oncologists, radiation oncologists, thoracic surgeons, respiratory physicians / pneumologists, interventional radiologists and pathologists all benefit from its comprehensive and stimulating programme. 

Make sure you connect to this highly interactive meeting and share your expertise with lung cancer specialists from around the world.

ELCC is a joint ESMO-IASLC congress, in partnership with ESTRO, ETOP and ESTS.

Access the ELCC 2024 programme here:

The European Lung Cancer Congress 2024 will provide insights into the prevention, diagnosis, biology and multi-disciplinary management of thoracic malignancies. Specifically, the Congress will include educational and scientific sessions covering:

  • Prevention, screening and early diagnosis of thoracic tumours;
  • Recent developments on molecular diagnosis and therapeutic classes for lung cancer;
  • New challenges and opportunities with immuno and targeted therapies;
  • The evolving role of multimodality and multidisciplinary decisions in lung cancer;
  • State of the art for NSCLC, SCLC, mesothelioma and mediastinal tumours

Abstract submission: 09 Jan 2024

Early registration: 17 Jan 2024

Late-breaking abstracts: 20 Feb 2024

Visit the ELCC webiste